Hypofractionated EGFR tyrosine kinase inhibitor limits tumor relapse through triggering innate and adaptive immunity
暂无分享,去创建一个
Mingyi Chen | yang-xin fu | Yang Wang | Longchao Liu | J. Qiao | A. Zhang | Zhenhua Ren | Changzheng Lu | Zhida Liu | Yang Pu | Chuanhui Han | Eric J Hsu | Aijun Shen | Chunbo Dong | C. Timmerman